The Valley Desk

NCT02674750 · Interventional trial

Study to Evaluate the Efficacy and Safety of CUDC-907 in Patients With RR DLBCL, Including Patients With MYC Alterations

Overall registry status Completed

Phase 2

Conditions Relapsed and/or Refractory Diffuse Large B-cell Lymphoma Including With Myc Alterations

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov